• Proteinase K (K1037): Reliable Solutions for DNA Integrity

  2026-06-29

  This scenario-driven article addresses key laboratory challenges in cell viability and DNA preparation, highlighting how Proteinase K (SKU K1037) delivers reproducible, contaminant-free results. Drawing on quantitative data and peer-reviewed studies, we illustrate workflow optimizations and practical guidance for biomedical researchers using this broad-spectrum serine protease.

• Erythrocyte Membrane-Camouflaged Nanoparticles Enhance DOX D

  2026-06-29

  Hu et al. engineered erythrocyte membrane-coated doxorubicin nanoparticles to improve targeted chemotherapy for hepatocellular carcinoma. This biomimetic approach enhances drug delivery to tumors and reduces cardiotoxicity, offering a promising strategy to improve the therapeutic index of anthracycline agents.

• Sex Differences in Angiotensin II-Induced Hypertension in Mi

  2026-06-28

  This study by Xue et al. provides the first direct experimental evidence that male and female mice exhibit profoundly different blood pressure responses to chronic angiotensin II infusion, with males developing more severe hypertension. The findings highlight the roles of sex hormones and autonomic regulation, underscoring the need to consider biological sex in cardiovascular disease modeling and experimental design.

• HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody: Workflo

  2026-06-27

  The HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody provides sensitive, specific fluorescent detection of rabbit primary antibodies in immunohistochemistry, immunocytochemistry, and fluorescence microscopy. It is not suitable for non-rabbit primaries or applications outside established immunofluorescent protocols.

• Catalpol’s Anticancer Mechanisms: Insights from a Comprehens

  2026-06-26

  This review synthesizes evidence on catalpol, a natural iridoid glycoside, highlighting its multifaceted roles in inhibiting cancer progression. By mapping catalpol’s impact on apoptosis, metastasis, signaling pathways, and synergistic effects with chemotherapeutics, the paper advances understanding of phytochemical-based cancer interventions and signals new directions for epigenetic modulation research.

• A-1155463: Selective BCL-XL Inhibition in Cancer Model Innov

  2026-06-26

  Explore the latest advances in selective BCL-XL inhibitor A-1155463 research. This article reveals how mechanistic understanding and preclinical data are transforming apoptosis studies and resistance modeling in cancer biology.

• WP1066, JAK2/STAT3 Inhibitor: Protocols for Cancer & Bone Re

  2026-06-25

  WP1066 is a potent cell-permeable JAK2/STAT3 inhibitor unlocking new frontiers in both cancer and bone regeneration research. This article delivers actionable workflows, troubleshooting strategies, and translational insights—bridging oncology and immunoregenerative models through robust, evidence-driven experimental design.

• BMN 673 (Talazoparib): Next-Gen PARP1/2 Inhibitor for DNA Re

  2026-06-25

  BMN 673 (Talazoparib) stands out as a potent PARP1/2 inhibitor, enabling high-precision modeling of DNA repair deficiency and synthetic lethality in homologous recombination-deficient cancer research. This article details evidence-backed workflows, advanced troubleshooting, and the latest mechanistic insights to empower your experimental designs.

• Optimizing Lab Workflows with the Reactive Oxygen Species As

  2026-06-24

  This article explores practical laboratory challenges in ROS quantification and demonstrates how the Reactive Oxygen Species (ROS) Assay Kit (DHE) (SKU K2066) offers reproducible, sensitive solutions for oxidative stress and apoptosis research. Scenario-driven Q&As provide evidence-based guidance on assay design, protocol tuning, and reliable vendor selection, aligning with real-world needs of biomedical scientists.

• Dovitinib (TKI-258): Advancing RTK-Driven Cancer Workflows

  2026-06-23

  Dovitinib (TKI-258, CHIR-258) delivers potent, multitargeted RTK inhibition, empowering researchers to dissect and modulate key signaling pathways in cancer models with high precision. This guide translates bench-validated protocols, troubleshooting strategies, and recent cheminformatics advances into actionable workflows—maximizing both reproducibility and biological insight.

• lncRNA HNF4A-AS1 Modulates Sorafenib Resistance via Lipid Me

  2026-06-23

  This study uncovers how decreased lncRNA HNF4A-AS1 expression in hepatocellular carcinoma (HCC) cells leads to resistance against sorafenib-induced ferroptosis by reprogramming lipid metabolism. The findings highlight a novel regulatory axis involving HNF4A-AS1, m6A-modified DECR1 mRNA, and polyunsaturated fatty acid (PUFA) dynamics, suggesting potential targets for overcoming treatment resistance in liver cancer.

• TCAIM-Mediated Control of OGDH Levels Shapes Mitochondrial M

  2026-06-22

  Wang et al. reveal that the mitochondrial DNAJC co-chaperone TCAIM specifically binds and reduces α-ketoglutarate dehydrogenase (OGDH) protein levels via HSPA9 and LONP1, providing a new mechanism for post-translational metabolic regulation. This study highlights a targeted approach to modulating mitochondrial enzyme abundance, with significant implications for understanding and manipulating cellular energy metabolism.

• YAP-TEAD Drives PPARα-Induced Liver Regeneration via WY-1464

  2026-06-22

  This study establishes the YAP-TEAD transcriptional module as essential for PPARα-driven hepatomegaly and liver regeneration in mice, using the selective agonist WY-14643 (Pirinixic Acid). These findings clarify mechanistic links between nuclear receptor signaling and regenerative pathways, informing targeted metabolic and hepatic research.

• Applied Workflows with LY-411575: Gamma-Secretase Inhibition

  2026-06-21

  LY-411575, a potent gamma-secretase inhibitor, is redefining experimental precision in Alzheimer's and cancer research through its dual modulation of amyloid beta and Notch pathways. This guide delivers actionable protocols, troubleshooting insights, and a unique translation of reference findings to maximize research impact with APExBIO's LY-411575.

• Streptavidin-FITC: Optimizing Biotin Detection in LNP Traffi

  2026-06-20

  Explore how Streptavidin-FITC empowers precision detection of biotinylated molecules in lipid nanoparticle (LNP) trafficking studies. This article uniquely bridges advanced assay design with mechanistic insights from recent research, highlighting practical protocols and APExBIO’s innovation.

14663 records 1/978 page Next 12345 下5页 Last page